Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
101.45
-3.05 (-2.92%)
May 8, 2026, 3:00 PM CST
4.80% (1Y)
| Market Cap | 26.85B +4.6% |
| Revenue (ttm) | 1.55B +52.1% |
| Net Income | 497.93M |
| EPS | 1.88 |
| Shares Out | 264.71M |
| PE Ratio | 53.94 |
| Forward PE | 48.46 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,306,940 |
| Average Volume | 3,563,447 |
| Open | 106.01 |
| Previous Close | 104.50 |
| Day's Range | 100.93 - 106.65 |
| 52-Week Range | 75.10 - 134.17 |
| Beta | 0.02 |
| RSI | 54.65 |
| Earnings Date | Apr 29, 2026 |